With HIV at or near the top of the specialty drug spending trend for both Medicaid and commercial payors, it’s important to improve managed care decision-making for patients with HIV, said experts in a 2020 PRIME Education webinar.
“HIV is associated with the highest per member per year cost for Medicaid in the specialty spend,” said Melissa Badowski, PharmD, MPH, a clinical associate professor of pharmacy practice, Section of Infectious Diseases Pharmacotherapy, at the